002166.SZ · 莱茵生物
China A-shares · RS rating 59 · As of 2026-10-14
| Price | 6.80 CNY |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 73 / 74 / 55 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 12 / 16 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.6% |
| Distance from 52-week high | +31.2% |
| Market cap (USD) | $809.6M |